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Efficient uncoating requires not only an optimal cellular environment, but also some intrinsic properties of the viral capsid protein itself. Using
an in vitro uncoating model, we demonstrated that substitution of each serine residue with alanine at the three major phosphorylation sites of HIV-
1 capsid protein, i.e. Ser-109, Ser-149 and Ser-178, could significantly reduce uncoating activity of purified core particles. We also showed that
the core stability of mutant viruses was lower than that of the wild-type virus so that the lack of efficient uncoating of each mutant could not be due
to an increase in capsid physical stability. However, serine-to-aspartic acid mutation to mimic the negative charge of phosphor-serine could not
restore either uncoating activity or infectivity, and treatment of purified core particles with a phosphatase did not alter the uncoating activity. Our
data indicated that mutations at phosphoacceptor sites of capsid disturbed the uncoating mechanism, but the defect may not be directly caused by
the lack of phosphate on the core particles undergoing uncoating.
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Capsid (CA) protein is the major structural component of
human immunodeficiency virus type 1 (HIV-1), forming a cone-
shaped core structure that surrounds the RNA genome at the
center of the virion. The HIV-1 CA must be able to assemble
properly and stable enough to protect the fragile genome while
being transmitted between cells or hosts, but must disassemble
or alter in the conformation sufficiently to allow genome release
after entry into target cells. The process that HIV-1 conical
capsid dissociates in order to release the viral genome is known
as uncoating. We previously reported the requirement of cell
cycle-dependent specific factors for HIV-1 uncoating. This
suggests that the uncoating process is not a spontaneous
process; on the other hand, this process is tightly regulated and
requires some specific triggers (Auewarakul et al., 2005).
Beside the requirement of the cellular environment that supports
HIV-1 uncoating, the capsid protein itself seems to play an
important role in the uncoating, too. Several HIV-1 capsid
functions have been analyzed by mutagenesis. In addition to the
mutations that perturb normal particle assembly, maturation and⁎ Corresponding author.
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capsid assembly but were nevertheless noninfectious by
implicating at the early steps of infection (Forshey et al.,
2002). These data indicate that the functions of capsid protein
do not only limit to the structural properties, but also important
for the regulation of viral life cycle such as uncoating and
subsequent reverse transcription.
Phosphorylation of viral protein often plays an important role
in regulation of viral replication. Several investigators reported
the requirement of virion structural protein phosphorylation, e.g.
herpes simplex virus type 1 (HSV-1) tegument protein VP22
(Morrison et al., 1998), vesicular stomatitis virus (VSV) matrix
(M) protein (Beckes et al., 1989; Kaptur et al., 1992) and
moloney murine leukemia virus (MMLV) p12 protein (Yueh and
Goff, 2003), for early post-entry event of the replication cycle.
One of the possible roles of the phosphorylation is modifying
these structural proteins leading to uncoating (Hui, 2002). For
HIV-1, a number of viral proteins have been shown to be
phosphorylated, including structural proteins, matrix (MA)
(Camaur et al., 1997; Kaushik and Ratner, 2004; Mervis et al.,
1988) and CA (Cartier et al., 1999; Henderson et al., 1992;
Mervis et al., 1988; Overton et al., 1989; Veronese et al., 1988).
The presence of cellular serine/threonine protein kinases
incorporated in HIV-1 particles was also demonstrated (Cartier
Fig. 1. Phosphorylation status of wild-type and mutant capsid protein (a). Viral
lysates obtained from 293T cells transfected with each mutant virus were
immunoprecipitated with an anti-p24 monoclonal antibody, separated by 12%
SDS-PAGE. Capsid protein phosphorylation was determined by staining with
Pro-Q Diamond phosphoprotein gel stain (upper panel). The total input of capsid
proteins from each mutant was demonstrated by silver stain (middle panel).
Phosphorylation of capsid proteins of mutant viruses relative to wild-type virus
was calculated from band densitometry of gels in the upper and lower panel.
Result is a representative of two independent experiments (lower panel).
Replication kinetics of viruses produced from transfection of 293T cell with
wild-type and mutant molecular clones (b). One ng p24 of each virus stock was
used to infect H9 cells and the infectivity was monitored by measurement of p24
released into supernatant. These data are a representative of three independent
experiments with similar results. , WT; , S109A; , S149A; ,
S178A; , S149D. Another set of similar experiment with higher input virus
(20 ng of p24) and measurements of viral production at early time points were
also performed (c).
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catalytic subunit of cAMP-dependent protein kinase (C-PKA)
was found to interact with and phosphorylate the CA protein. C-
PKA activity affected infectivity but was not required for
maturation and assembly (Cartier et al., 2003). In addition, it has
been demonstrated that the target of phosphorylation is on serine
residues (Cartier et al., 1999; Mervis et al., 1988). Mutagenesis
performed on highly conserved serine residues could uncover
the three major phosphorylation sites within CA protein, i.e. Ser-
109, Ser-149 and Ser-178. Substitution of each serine residue
with alanine did not affect viral budding nor viral structure, by
contrast, it affected viral infectivity by preventing the reverse
transcription process to be completely achieved (Cartier et al.,
1999). These data led to a hypothesis that HIV-1 CA
phosphorylation may be required for viral uncoating process.
We sought to identify residues on capsid protein that are
essential for the uncoating by testing specific capsid mutants
that were previously shown to support normal core assembly
but lack infectivity, including the phosphoacceptor site mutants.
Results
CA phosphorylation level and viral infectivity of the wild-type
and mutant viruses
To authenticate that CA point mutations at serine residues
109, 149 and 178 affected phosphorylation status of CA protein,
wild-type and the CA mutated viruses were immunoprecipitated
by anti-HIV p24 and detected for phosphorylation using Pro-Q
Diamond phosphoprotein gel stain. As demonstrated in Fig. 1a,
phosphorylation status of the mutant CA proteins was
significantly less than that of wild-type CA protein (upper
panel). Similar amounts of CA protein from each virus were
added and were identified by silver stain (middle panel). Band
densitometry was performed and the phosphorylation of each
mutant CA protein relative to wild-type CA protein was
calculated from band densitometry of the silver stain and Pro-Q
phosphorylation staining gels (lower panel). The results,
therefore, substantiated that mutation at serine 109, 149 and
178 reduced the phosphorylation level of CA protein.
These mutants were then determined for the viral infectivity.
H9 cells were incubated with the wild-type and mutant viruses
that had been harvested from supernatant of transfected 293T
cells. Cultured medium was tested for p24 released in super-
natant by ELISA. As shown in Fig. 1b, no p24 released into
supernatant of H9 cell cultures which inoculated with S109A,
S149A and S178A mutants. On the other hand, wild-type virus
could replicate efficiently in cultured H9 cells. Thus, these three
mutants were not infectious in H9 cell and suggested that
phosphorylation of CA protein was required for HIV-1
infectivity.
Mutation at CA phosphor-acceptor sites affects uncoating
activity
To characterize whether the substitution of these serine
residues blocks HIV-1 infection at the uncoating step, theuncoating activity of core particles derived from each virus were
measured using the in vitro uncoating assay described
previously in our laboratory (Auewarakul et al., 2005). Because
the uncoating process is defined as the disassembly of viral core
in an intracellular environment, an approach to study this
process is to detect the disassembly of core particles in the
presence of cellular constituent. Core particles purified from
each mutant virus were incubated with H9 cell lysate. The
extent of uncoating was determined by measuring the level of
p24 in the supernatant after ultracentrifugation. We have
previously verified that the assay indeed measured a structural
disassembly of core particles. The disassembly was not due to
any non-specific physical conditions and required a specific
cellular component from permissive cells. The assay should
therefore accurately reflect the viral uncoating process. Using
Fig. 2. Uncoating activity of wild-type and the phosphoacceptor site-mutant
core particles. The relative uncoating efficiencies are shown in percent of
complete disassembly by p24 disruption buffer. The bars represent uncoating
activity of core particle from each mutant in the presence of H9 cell lysate
(2.5×104 cells/μl). The bars represent means of 3 separated experiments and
the error bars are 1 SD.
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residues led to a decrease in uncoating activity. As shown in Fig.
2, uncoating activity of S109A, S149A and S178A mutant
viruses was 6, 3 and 1.6 times lower than that of wild-type virus
respectively. This indicated that CA phosphorylation played an
important role in HIV-1 uncoating.
Effect of CA phosphor-acceptor site mutations on core stability
To exclude the possibility that the decrease in uncoating
activity of these mutants was due to increase in stability of
virion core, we characterized the core stability of these wild-
type and mutant viruses by comparing yield of core particles of
each virus after purification by the spin-through technique. The
yields of cores were calculated by determining the amount of
CA pellets as a percentage of total input CA (Forshey et al.,
2002). As shown in Fig. 3, the core yield from wild-type virus
was approximately 11% of the input virus. In contrast, the yields
of core particles from these mutant viruses were around 4% to
6% of the input virus. This result indicated that the core stability
of mutant viruses was lower than that of the wild-type virus and
the lack of efficient uncoating of each mutant could not be due
to an increase in capsid physical stability.Fig. 3. Physical stability of wild-type and mutant core particles. Concentrated virio
ultracentrifugation, yields of core particles were calculated by measuring the amoun
separated experiments and the error bars are 1 SD.Substitution of serine with aspartic acid cannot restore
infectivity and uncoating activity
Phosphorylation of a protein causes an increase in negative
charge. Therefore, it is possible that the effects of phosphoryla-
tion could be mimicked by the addition of negative charge at the
phosphorylation site. To determine this hypothesis, we replaced
the Ser-149 with aspartic acid residue. We used this construct to
studied viral infectivity as well as uncoating activity and
stability of purified core particle. S149D mutant could not
restore the viral infectivity (Fig. 1b). Substitution of serine
residue with aspartic acid could only slightly restore the
uncoating activity. As shown in Fig. 2, the uncoating activity of
S149D was a little higher than S149A, but still significantly less
than that of wild-type virus: approximately half of wild-type
virus. The stability of this mutant core particle was also less than
wild-type core and was comparable to that of S149A core
particle (Fig. 3). This suggested that a negative charge residue
could not mimic the roles of CA phosphorylation in viral
infectivity and uncoating.
Phosphatase treatment did not affect the uncoating
In order to test whether the uncoating defect was directly due
to the lack of phosphate group at the phosphoacceptor sites or
indirectly due to other changes caused by the mutations, we
treated purified core particles from the wild-type virus and
tested for the uncoating activity. The enzymatic treatment
successfully got rid of phosphate from the core as shown by a
marked reduction in band intensity in a Pro-Q phosphorylation
staining gel (Fig. 4). This also served as a control that the
staining could semiquantitatively detect phosphorylation status
of proteins. However, the uncoating of the treated and untreated
core was not significantly different. This indicated that depho-
sphorylated cores could still undergo normal uncoating process,
and the presence of phosphate on the CA protein was not
required for the uncoating.
Other mutations with decreased physical stability did not show
uncoating defect
The three phosphoacceptor site mutations showed decreased
physical stability while resisting to uncoating by cell lysate. Inns were loaded on top of 10% sucrose containing 0.1% Igepal CA-630. After
t of CA pellets as a percentage of total input CA. The bars represent means of 3
Fig. 4. Wild-type core particles with and without phosphatase treatment were immunoprecipitated, separated by SDS-PAGE and stained with Pro-Q Diamond
phosphoprotein stain (a). The treated core showed markedly reduced staining indicating that the phosphatase treatment had successfully dephosphorylated the proteins.
The uncoating activity of the treated core was, however, comparable to the control untreated core (b).
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defect was specific to the uncoating mechanism and not simply
due to non-specific structural changes, we tested other two CA
mutations (K170A and K203A) that were previously shown to
be defective in an early post-entry event and have decreased
physical stability (Forshey et al., 2002). These two mutants
were uncoated at least as efficiently as the wild-type virus (Fig.
5). This suggested that altered physical stability could not cause
uncoating defect that was observed in the phosphoacceptor site
mutants.
Discussion
The uncoating process of many viruses was shown to require
specific cellular factors as well as intrinsic viral properties
(Greber et al., 1994; Sansom et al., 1998; Singh and Helenius,
1992; Smyth and Martin, 2002; Wharton et al., 1994). For HIV-
1, we previously showed that the uncoating required the specific
cellular factors (Auewarakul et al., 2005). In the present study,
we identified specific residues on the CA protein required for
the uncoating.Fig. 5. Uncoating activity of mutants those were previously shown to have
decreased core stability. The relative uncoating efficiencies are shown in percent
of complete disassembly by p24 disruption buffer. The bars represent uncoating
activity in the presence of H9 cell lysate (2.5×104 cells/μl). The bars represent
means of 3 separated experiments and the error bars are 1 SD.Cartier et al. has previously demonstrated that alanine
substitution at the phosphorylation sites of serine residue 109,
149 and 178 of the CA protein could suppress the viral ability to
replicate in T cell lines at an early post-entry step. The assembly
and maturation process of these mutants were demonstrated to
be intact (Cartier et al., 1999). We demonstrate here that the step
in viral life cycle that is likely to be affected by phosphorylation
site mutations was the uncoating process.
Efficient uncoating requires these three serine residues
simultaneously. The mature capsid comprises hexameric rings
of CA protein held together by a dimeric interaction of CA
between adjacent rings (Li et al., 2000). The C-domain to C-
domain dimeric interaction is stable while the N-domain to N-
domain hexameric interaction is not and could only exist with
intact C-domain to C-domain and N-domain to C-domain
intermolecular interactions (Lanman et al., 2003). According to
the high-resolution structure, Ser-149 is located in the
unstructured inter-domain linker, which is disordered in the
monomer but forms structured interactions upon assembly
(Berthet-Colominas et al., 1999; Lanman et al., 2003). Ser-178
is situated between helix 8 and 9 in the C-domain near the C-
domain dimerization interface (residues 179–192) (Gamble et
al., 1997; Momany et al., 1996). Therefore, structural
modification at these two serine residues may facilitate the
disassembly of core particle, possibly by alteration the C-
domain to C-domain interaction as we have proposed in the
previous report (Auewarakul et al., 2005). The uncoating might
not be due to the repulsion force from the negatively charged
phosphate group as we demonstrated that substitution of Ser-
149 with aspartic acid could not restore infectivity and
uncoating activity. On the other hand, the substitution might
not only mimic the positive charge but also alter some essential
conformation, which led to the loss of uncoating and infectivity.
The Ser-109 might be involved in the binding site of the
putative uncoating factor since the position of Ser-109 is
between helix 5 and 6 in the amino-terminal which is likely to
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protein–protein interface.
The lack of effect of phosphatase treatment on the uncoating
suggests that incoming core does not need to be phosphorylated
in order to be uncoated. However, it is intriguing that all the
mutations at the phosphoacceptor sites showed uncoating
defect, while mutations at other positions showing similarly
decreased core physical stability were not defective in
uncoating. This suggests that the phosphorylation may be
important for the uncoating. It is also possible that the CA
protein is phosphorylated while undergoing uncoating in the
cell lysate or the target cell. Recently, Amella et al. (2005)
demonstrated that inhibition of the kinase C-PKA in target cells
significantly inhibited synthesis of HIV-1 DNA without
affecting viral entry. More studies are needed to elucidate this
obscure process in the HIV replication.
Materials and methods
DNA constructs and site-directed mutagenesis
The plasmid pNL4-3 was used as the parental viral DNA
clone. The pNL4-3 gag fragment containing nucleotide number
113 to 2010 was inserted into pGEM-T vector and propagated
in Escherichia coli JM109. To generate the mutants, two
oligonucleotides were used to prime DNA synthesis by Pfu
DNA polymerase on a denatured DNA template. The
oligonucleotide primers that were used to generate each mutant
are shown in Table 1. The thermal cycle was 16 cycles of 95 °C
for 30 s, 55 °C for 60 s and 68 °C for 10 min. Because of the
background of wild-type plasmid DNA, the mutant molecules
were enriched by using the restriction enzyme DpnI, which
specifically cleaved fully methylated GMe6ATC sequences.
DpnI digested the bacterially generated DNA used as template
for amplification, but it did not digest DNA synthesized during
the course of the reaction in vitro. The reaction was transformed
into E. coli JM109. Individual clones were picked up and the
mutations were then verified by DNA sequencing. The correct
mutants were cloned back into the parental infectious clone,
pNL4-3.Table 1
Primers used in site-directed mutagenesis
Mutant Primer Sequence
S109A Sense 5′-AACTACTGCTACCCTTCAGGAACAAATA-3′
Antisense 5′-TGAAGGGTAGCAGTAGTTCCTGCTATG-3′
S149A Sense 5′-AGCCCTACCGCCATTCTGGACATAAGAC-3′
Antisense 5′-TCCAGAATGGCGGTAGGGCTATACATTC-3′
S178A Sense 5′-AGCAAGCTGCACAAGAGGTAAAAAATTGG-3′
Antisense 5′-TACCTCTTGTGCAGCTTGCTCGGCTCT-3′
S149D Sense 5′-AGCCCTACCGACATTCTGGACATAAGAC-3′
Antisense 5′-TCCAGAATGTCGGTAGGGCTATACATTC-3
K170A Sense 5′-ACCGATTCTATGCAACTCTAAGAGCCGAG-3′
Antisense 5′-TCTTAGAGTTGCATAGAATCGGTCTACATAG-3′
K203A Sense 5′-ACTATTTTAGCAGCATTGGGACCAGGAG-3′
Antisense 5′-TCCCAATGCTGCTAAAATAGTCTTACAATC-3′
The underlined codons were the mutated codons.Cell culture and virus production
To generate the viruses, the DNA constructs were transfected
into 293T cells using SuperFect® Transfection Reagent (QIA-
GEN). Five micrograms of each plasmid DNAwas diluted with
DMEM without serum, proteins or antibiotics to a total volume
of 150 μl and then mixed with 30 μl of SuperFect® Transfection
Reagent. The samples were incubated for 5–10 min at room
temperature to allow transfection complex formation, and 1 ml
of Dulbecco's modified Eagle's medium (DMEM) supplemen-
ted with 10% fetal bovine serum (FBS), penicillin (100 units/ml)
and streptomycin (100 μg/ml) was added to the reaction tube
containing the transfection complex. After 2 h of incubation
of 293T cells (40% confluence) with the transfection com-
plexes at 37 °C, DMEM containing the remaining complexes
was removed from the cells and replaced by 5 ml of DMEM
supplemented with 10% FBS and antibiotics. The super-
natants were harvested on day 3 and assayed for p24 level
using an antigen-captured ELISA (Vironostika®, Organon
Teknika).
Phosphorylation assay
CA proteins of wild-type and mutant virions were immuno-
precipitated by anti-HIV p24 (MoAb2 ARP454) and detected
for phosphorylation using Pro-Q Diamond phosphoprotein gel
stain (Molecular Probes, Eugene, Oregon). Virions were lysed
in 1% NP-40 at room temperature for 1 h. The lysates were
incubated with NET buffer (50 mM Tris–Cl pH 7.5, 150 mM
NaCl, 0.5% NP-40 and 1 mM EDTA pH 8.0) containing anti-
HIV p24 antibody for 1 h at 4 °C on a rocking platform. Fifty
microliters of protein A-Sepharose was added to the antigen/
antibody mixture, and the mixture was incubated for 1 h at 4 °C
on a rocking platform. The complex then were collected by
centrifugation at 12,000 rpm for 20 s at 4 °C in a microfuge, and
washed twice with 1 ml NET buffer then once with 10 mM
Tris–Cl pH 7.5, 0.1% NP-40 for 20 min per wash. The pellet
was mixed with Western blot loading buffer, heated in boiling
water bath for 5 min, centrifuged and the amount of p24 in the
supernatant was measured by an antigen-captured ELISA
(Vironostika®, Organon Teknika). Supernatant with equal
amount of p24 was loaded onto a 12% SDS-polyacrylamide gel.
Fluorescent staining of SDS-polyacrylamide gels using
Pro-Q Diamond phosphoprotein gel stain was performed by
fixing the gels in 45% methanol, 5% acetic acid overnight,
washing with three changes of deionized water for 10 to 20 min
per wash, followed by incubation in Pro-Q Diamond phospho-
protein gel stain for 180 min and destaining with three
successive washes of 4% acetonitrile in 50 mM sodium acetate
pH 4.0 (Schulenberg et al., 2003). The state of phosphorylation
was visualized under a UV transluminator.
The phosphorylation of the CA protein in virus produced
from each mutant relative to wild-type virus was calculated
from band densitometry data as the band intensity of the Pro-Q
staining divided by the band intensity of Silver staining (Pro-Q/
Silver ratio) in the virus mutant, divided by the Pro-Q/Silver
ratio for the CA protein of wild-type virus.
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Equal amount of wild-type and mutant viruses normalized by
amount of p24 was incubated with 1×106 H9 cells at 37 °C for
3 h. The input viruses were removed by washing with four
changes of 1 ml PBS and plated in 2 ml of RPMI1640 with 10%
FBS in a 6-well plate. Virus infectivity was determined by
measurement of p24 released in supernatant every 4 days using
the antigen-captured ELISA.
Purification of HIV-1 core particles
Viral core particles were purified by a spin-through
technique with some modification as previously described
(Auewarakul et al., 2005). Three milliliters of cell-free super-
natant containing wild-type and mutant virions was overlaid on
a discontinuous sucrose density gradient. The gradient was
composed of 1 ml of 50% sucrose at the bottom and 1 ml of
10% sucrose containing 0.1% Igepal CA-630 on the top. The
overlaid gradient was then centrifuged at 100,000×g in a
SW50.1 rotor (Beckman™) for 2 h at 4 °C. The pellet
containing viral core particles was then resuspended in 10 μl of
PBS, pooled and stored in aliquots at −80 °C. The core particles
were quantitated by measuring the capsid p24 antigen with
ELISA.
Cell lysate preparation
H9 cell lysate (25×106cells/ml) was prepared by resuspend-
ing washed cell pellets in hypotonic lysis buffer (10 mM Tris,
pH 7.4, 1.5 mM MgCl2, 10 mM KCl and 0.5 mM DTT). The
cell suspension was frozen and thawed, incubated on ice for
10 min and centrifuged at 12,000 rpm in a refrigerated
microcentrifuge for 5 min. The supernatant was then stored at
−80 °C until used in uncoating assay.
Uncoating assay
Wild-type and mutant core particles (1 ng in 2 μl of PBS)
were incubated with 2 μl of H9 cell lysate at 37 °C for 30 min,
then diluted in 5 ml of PBS and centrifuged at 100,000×g in a
SW50.1 rotor (Beckman™) for 2 h at 4 °C. Incubations with
hypotonic lysis buffer and p24 disruption buffer (Vironostika®,
Organon Teknika) were done in parallel as negative and positive
controls. The level of core disintegration was determined by
measuring the level of p24 in the supernatant after centrifuga-
tion. The complete disruption of core by p24 disruption buffer
was considered 100%, and percent disruption by lysates was
calculated accordingly.
Phosphatase treatment
Core particle containing 5 ng of p24 antigen was treated with
50 units of Antarctic phosphatase (New England Biolab) in the
supplied buffer at 37 °C for 60 min in a 20 μl reaction. A control
reaction without the enzyme was performed in parallel. One
microliter of the reactions was diluted in 2.5 μl of PBS, and 1 μlof these diluted cores was then used in the uncoating assay. The
rest of the treated cores were immunoprecipitated and were
detected for their phosphorylation status by Pro-Q Diamond
phosphoprotein gel stain.
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